ILKe Nalbantoglu, MD
Titles
- Associate Professor of Pathology
Education & Training
- MDEge University School of Medicine, M.D.
Additional Information
Publications
- Castrodad-Rodríguez C, Cheng J, Westerhoff M, Liang G, Lin J, Nalbantoglu I, Hu S, Sekhri R, Panarelli N. Clinical and Pathological Correlation in Concomitant Celiac Disease and Eosinophilic Esophagitis Suggests Separate Etiologies. International Journal Of Surgical Pathology 2023, 32: 27-34. PMID: 37050846, DOI: 10.1177/10668969231167526.
- Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development.Tan W, Tian M, Ruzgar N, Hengartner A, Sailo B, Ang-Olson O, Ubas A, John N, Yaghoobi V, Tang H, Sharma A, Nalbantoglu I, Ahuja N. Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development. Journal Of Clinical Oncology 2023, 41: 189-189. DOI: 10.1200/jco.2023.41.4_suppl.189.
- Nalbantoglu I, Misdraji J. Approach to the liver biopsy diagnosis of adult cholangiopathies. Diagnostic Histopathology 2023, 29: 23-35. DOI: 10.1016/j.mpdhp.2022.10.004.
- Byrnes K, Vachharajani N, Doyle MM, Nalbantoglu I. Liver allograft findings of donation after cardiac death versus brain death in recipients with hepatitis C related cirrhosis: a matched histologic comparison. Human Pathology 2022, 122: 25-31. PMID: 35085598, DOI: 10.1016/j.humpath.2022.01.005.
- Verma A, Nalbantoglu I, Barbieri A. Metastatic Neoplasms of the Large Bile Ducts- A Clinicopathological Study. American Journal Of Clinical Pathology 2021, 156: s58-s58. DOI: 10.1093/ajcp/aqab191.119.
- Hu X, Lucas E, Hammer S, Gopal P, Bhalla A, Panarelli N, Westerhoff M, Cheng J, Nalbantoglu I. H. pylori Pattern Gastritis with Negative Helicobacter Immunohistochemical Stain: Does A Specific Comment in Pathology Report Impact Clinical Management? American Journal Of Clinical Pathology 2021, 156: s67-s68. DOI: 10.1093/ajcp/aqab191.140.
- Gibson JA, Finberg KE, Nalbantoglu I, Cecchini M, Ganzak A, Walther Z, Sklar JL, Eder JP, Goldberg SB. Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan. The Lancet Oncology 2021, 22: 306-307. PMID: 33662283, DOI: 10.1016/s1470-2045(20)30683-5.
- Abu‐Alreesh S, Rosen D, Nalbantoglu I, Arbizu RA. Gastric Xanthoma. Journal Of Pediatric Gastroenterology And Nutrition 2021, 73: e26-e26. PMID: 33605661, DOI: 10.1097/mpg.0000000000003085.
- Blanc V, Riordan JD, Soleymanjahi S, Nadeau J, Nalbantoglu I, Xie Y, Molitor EA, Madison BB, Brunt EM, Mills JC, Rubin DC, Ng I, Ha Y, Roberts LR, Davidson NO. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis and hepatocellular cancer. Journal Of Clinical Investigation 2021, 131 PMID: 33445170, PMCID: PMC7773377, DOI: 10.1172/jci138699.
- González IA, Hartley CP, Nalbantoglu I. Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft. American Journal Of Clinical Pathology 2020, 155: 435-445. PMID: 33252121, DOI: 10.1093/ajcp/aqaa147.
- Aranake-Chrisinger J, Dassopoulos T, Yan Y, Nalbantoglu I. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation. World Journal Of Gastroenterology 2020, 26: 4126-4139. PMID: 32821074, PMCID: PMC7403798, DOI: 10.3748/wjg.v26.i28.4126.
- Blanc V, Xie Y, Riordan J, Nadeau J, Nalbantoglu I, Soleymanjahi S, Madison B, Brunt E, Molitor E, Mills J, Ng I, Ha Y, Roberts L, Davidson N. 691 RNA BINDING PROTEIN APOBEC1 COMPLEMENTATION FACTOR (A1CF) ALTERS HEPATIC LIPOGENIC AND PROLIFERATIVE PATHWAYS PROMOTING SPONTANEOUS TUMORIGENESIS. Gastroenterology 2020, 158: s-1286. DOI: 10.1016/s0016-5085(20)33879-8.
- Tang H, Sharma A, Nalbantoglu I, Hasan N, Levchenko A, Ahuja N. Abstract C54: GATA6 level is a prognostic biomarker for pancreatic cancer in African American patients. Cancer Research 2019, 79: c54-c54. DOI: 10.1158/1538-7445.panca19-c54.
- Nalbantoglu I, Jain D. Cryptogenic cirrhosis: Old and new perspectives in the era of molecular and genomic medicine. Seminars In Diagnostic Pathology 2019, 36: 389-394. PMID: 31395291, DOI: 10.1053/j.semdp.2019.07.003.
- Yang C, Tarabishy Y, Dassopoulos T, Nalbantoglu I. Clinical, Histologic, and Immunophenotypic Features of Serrated Polyps in Patients With Inflammatory Bowel Disease. Gastroenterology Research 2018, 11: 355-360. PMID: 30344807, PMCID: PMC6188039, DOI: 10.14740/gr1064w.
- Joseph NM, Brunt EM, Marginean C, Nalbantoglu I, Snover DC, Thung SN, Yeh MM, Umetsu SE, Ferrell LD, Gill RM. Frequent GNAQ and GNA14 Mutations in Hepatic Small Vessel Neoplasm. The American Journal Of Surgical Pathology 2018, 42: 1201-1207. PMID: 29975248, DOI: 10.1097/pas.0000000000001110.
- Liss KHH, McCommis KS, Chambers KT, Pietka TA, Schweitzer GG, Park SL, Nalbantoglu I, Weinheimer CJ, Hall AM, Finck BN. The impact of diet‐induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury. Liver Transplantation 2018, 24: 908-921. PMID: 29729104, PMCID: PMC6097916, DOI: 10.1002/lt.25189.
- Gopal P, Gibson JA, Lisovsky M, Nalbantoglu I. Unique causes of esophageal inflammation: a histopathologic perspective. Annals Of The New York Academy Of Sciences 2018, 1434: 219-226. PMID: 29766506, DOI: 10.1111/nyas.13732.
- Zhang X, Patil D, Odze RD, Zhao L, Lisovsky M, Guindi M, Riddell R, Bellizzi A, Yantiss RK, Nalbantoglu I, Appelman HD. The microscopic anatomy of the esophagus including the individual layers, specialized tissues, and unique components and their responses to injury. Annals Of The New York Academy Of Sciences 2018, 1434: 304-318. PMID: 29761508, DOI: 10.1111/nyas.13705.
- Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A. Genomic regions associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study. PLOS ONE 2017, 12: e0184962. PMID: 29073141, PMCID: PMC5657624, DOI: 10.1371/journal.pone.0184962.
- Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, Heiken JP, Fowler KJ. Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014. Radiology 2017, 286: 158-172. PMID: 28853673, DOI: 10.1148/radiol.2017170114.
- Pehlivanoglu B, Hassoy H, Calle C, Dendooven A, Nalbantoglu I, Reshchikova L, Gul G, Doganavsargil B. How does it feel to be a pathology resident? Results of a survey on experiences and job satisfaction during pathology residency. Virchows Archiv 2017, 471: 413-422. PMID: 28624995, DOI: 10.1007/s00428-017-2167-2.
- McCommis KS, Hodges WT, Brunt EM, Nalbantoglu I, McDonald WG, Holley C, Fujiwara H, Schaffer JE, Colca JR, Finck BN. Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis. Hepatology 2017, 65: 1543-1556. PMID: 28027586, PMCID: PMC5397348, DOI: 10.1002/hep.29025.
- Olsen S, Jin L, Fields RC, Yan Y, Nalbantoglu I. Tumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrence. Human Pathology 2017, 68: 26-33. PMID: 28428104, DOI: 10.1016/j.humpath.2017.03.021.
- Sun X, Chandar A, Canto M, Thota P, Brock M, Shaheen N, Beer D, Wang J, Falk G, Iyer P, Abrams J, Venkat-Ramani M, Veigl M, miron A, Willis J, Patil D, Nalbantoglu I, Guda K, Markowitz S, zhu X, Elston R, Chak A. Sa1139 Identification of Genomic Regions Associated with Susceptibility to Barrett’s Esophagus and Esophageal Adenocarcinoma in African Americans: The Cross Betrnet Admixture Study. Gastroenterology 2017, 152: s233. DOI: 10.1016/s0016-5085(17)31069-7.
- Randolph GJ, Bala S, Rahier JF, Johnson MW, Wang PL, Nalbantoglu I, Dubuquoy L, Chau A, Pariente B, Kartheuser A, Zinselmeyer BH, Colombel JF. Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease. American Journal Of Pathology 2016, 186: 3066-3073. PMID: 27746181, PMCID: PMC5225286, DOI: 10.1016/j.ajpath.2016.07.026.
- Lang G, Nalbantoglu I, Early D, Mullady D, Kushnir V. High Recurrence Rate of Large Hyperplastic Polyps After Endoscopic Resection. The American Journal Of Gastroenterology 2016, 111: s499. DOI: 10.14309/00000434-201610001-01148.
- Nalbantoglu I, Blanc V, Davidson NO. Characterization of Colorectal Cancer Development in Apcmin/+ Mice. 2016, 1422: 309-327. PMID: 27246043, PMCID: PMC5061497, DOI: 10.1007/978-1-4939-3603-8_27.
- Pehlivanoğlu B, Doğanavşargil B, Sezak M, Nalbantoğlu İ, Korkmaz M. Gastrointestinal Parasitosis: Histopathological Insights to Rare But Intriguing Lesions of the Gastrointestinal Tract. Turkish Journal Of Pathology 2016, 32: 82-90. PMID: 27136106, DOI: 10.5146/tjpath.2015.01350.
- Gill RM, Buelow B, Mather C, Joseph NM, Alves V, Brunt EM, Liu TC, Makhlouf H, Marginean C, Nalbantoglu I, Sempoux C, Snover DC, Thung SN, Yeh MM, Ferrell LD. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Human Pathology 2016, 54: 143-151. PMID: 27090685, PMCID: PMC5242228, DOI: 10.1016/j.humpath.2016.03.018.
- Randolph G, Bala S, Rahier J, Wang P, Zinselmeyer B, Nalbantoglu I, Cella M, Colonna M, Newberry R, Dubuquoy L, Chau A, Pariente B, Kartheuser A, Colombel J. Sa1866 Mesenteric Lymphatic and Venous Vasculopathy in Crohn's Disease. Gastroenterology 2016, 150: s385. DOI: 10.1016/s0016-5085(16)31355-5.
- Sayuk G, Nalbantoglu I, Hasak S, Rubin D, Nix B, Gyawali C, Patel A. Mo1649 High Colonic Mast Cell Counts May Be Associated with Lower Extra-intestinal Comorbidity in Irritable Bowel Syndrome (IBS). Gastroenterology 2016, 150: s742. DOI: 10.1016/s0016-5085(16)32520-3.
- Doyle MB, Collins K, Vachharajani N, Lowell JA, Shenoy S, Nalbantoglu I, Byrnes K, Garonzik-Wang J, Wellen J, Lin Y, Chapman WC. Outcomes Using Grafts from Donors after Cardiac Death. Journal Of The American College Of Surgeons 2015, 221: 142-152. PMID: 26095563, DOI: 10.1016/j.jamcollsurg.2015.03.053.
- Lin J, Cummings OW, Greenson JK, House MG, Liu X, Nalbantoglu I, Pai R, Davidson DD, Reuss SA. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma. Scandinavian Journal Of Gastroenterology 2015, 50: 447-453. PMID: 25635498, DOI: 10.3109/00365521.2014.962603.
- Kushnir VM, Nalbantoglu I, Watson R, Goodwin J, Safar E, Chokshi RV, Azar RR, Davidson NO. Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Digestive Diseases And Sciences 2014, 59: 2757-64. PMID: 24925148, PMCID: PMC4213267, DOI: 10.1007/s10620-014-3245-9.
- Nalbantoglu I, Tan B, Linehan D, Gao F, Brunt E. Oxaliplatin‐induced liver injury. Journal Of Digestive Diseases 2014, 15: 553-560. PMID: 25060628, DOI: 10.1111/1751-2980.12177.
- Giammanco A, Blanc V, Montenegro G, Klos C, Xie Y, Kennedy S, Luo J, Chang SH, Hla T, Nalbantoglu I, Dharmarajan S, Davidson NO. Intestinal Epithelial HuR Modulates Distinct Pathways of Proliferation and Apoptosis and Attenuates Small Intestinal and Colonic Tumor Development. Cancer Research 2014, 74: 5322-5335. PMID: 25085247, PMCID: PMC4167566, DOI: 10.1158/0008-5472.can-14-0726.
- Nalbantoglu I, Brunt E. Role of liver biopsy in nonalcoholic fatty liver disease. World Journal Of Gastroenterology 2014, 20: 9026-37. PMID: 25083076, PMCID: PMC4112884, DOI: 10.3748/wjg.v20.i27.9026.
- Blanc V, Klos C, Giammanco A, Montenegro G, Xie Y, Kennedy S, Luo J, Chang S, Nalbantoglu I, Hla T, Dharmarajan S, Davidson N. 294 Conditional Intestine-Specific HuR Deletion (HuR-IKO) Modulates Distinct Wnt-Dependent and Independent Pathways of Proliferation and Apoptosis With No Effect on Ileal ASBT Expression or Bile Acid Metabolism. Gastroenterology 2014, 146: s-70. DOI: 10.1016/s0016-5085(14)60253-5.
- Tarabishy Y, Nalbantoglu I. Su1305 Clinical, Endoscopic, and Histologic Features With Utilization of Ki67 Staining in Serrated Polyps in Patients With Inflammatory Bowel Disease. Gastroenterology 2014, 146: s-431-s-432. DOI: 10.1016/s0016-5085(14)61551-1.
- Kushnir V, Nalbantoglu I, Watson R, Chokshi R, Safar E, Goodwin J, Azar R, Davidson N. 674 Advanced Colorectal Adenomas in Patients Under 45 Years of Age Are Mostly Sporadic. Gastroenterology 2014, 146: s-119. DOI: 10.1016/s0016-5085(14)60428-5.
- Zhang C, Zhao Z, Osman H, Watson R, Nalbantoglu I, Lin J. Differential expression of miR-31 between inflammatory bowel disease and microscopic colitis. MicroRNA 2014, 3: 155-9. PMID: 25665881, DOI: 10.2174/2211536604666150209115444.
- Asombang A, Safar B, Wang J, Nalbantoglu I. Is a Rectal Mass and Lymphadenopathy Always Rectal Cancer? The American Journal Of Gastroenterology 2013, 108: s360. DOI: 10.14309/00000434-201310001-01228.
- Dharmarajan S, Newberry EP, Montenegro G, Nalbantoglu I, Davis VR, Clanahan MJ, Blanc V, Xie Y, Luo J, Fleshman JW, Kennedy S, Davidson NO. Liver Fatty Acid-Binding Protein (L-Fabp) Modifies Intestinal Fatty Acid Composition and Adenoma Formation in ApcMin/+ Mice. Cancer Prevention Research 2013, 6: 1026-1037. PMID: 23921281, PMCID: PMC3791217, DOI: 10.1158/1940-6207.capr-13-0120.
- Xie Y, Matsumoto H, Nalbantoglu I, Kerr TA, Luo J, Rubin DC, Kennedy S, Davidson NO. Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer. PLOS ONE 2013, 8: e67819. PMID: 23805328, PMCID: PMC3689718, DOI: 10.1371/journal.pone.0067819.
- Montenegro G, Giammanco A, Blanc V, Kennedy S, Luo J, Chang S, Nalbantoglu I, Hla T, Davidson N. Tu1732 Conditional Intestinal-Epithelial Specific HuR Deletion Modifies Murine Intestinal Tumorigenesis. Gastroenterology 2013, 144: s-833. DOI: 10.1016/s0016-5085(13)63096-6.
- Giammanco A, Blanc V, Montenegro G, Kennedy S, Luo J, Chang S, Nalbantoglu I, Hla T, Davidson N. 230 Conditional Intestine-Specific HuR Deletion (HuR-Iko) Modifies Epithelial Growth, Response to Injury and Tumorigenesis. Gastroenterology 2013, 144: s-50. DOI: 10.1016/s0016-5085(13)60176-6.
- Dharmarajan S, Newberry E, Nalbantoglu I, Davis V, Montenegro G, Blanc V, Xie Y, Luo J, Kennedy S, Davidson N. 82 Modulating Intestinal Fatty Acid Flux Attenuates Intestinal Tumorigenesis in APC MIN/+ Mice. Gastroenterology 2013, 144: s-18. DOI: 10.1016/s0016-5085(13)60062-1.
- Carvalho FA, Koren O, Goodrich JK, Johansson ME, Nalbantoglu I, Aitken JD, Su Y, Chassaing B, Walters WA, González A, Clemente JC, Cullender TC, Barnich N, Darfeuille-Michaud A, Vijay-Kumar M, Knight R, Ley RE, Gewirtz AT. Transient Inability to Manage Proteobacteria Promotes Chronic Gut Inflammation in TLR5-Deficient Mice. Cell Host & Microbe 2012, 12: 139-152. PMID: 22863420, PMCID: PMC4310462, DOI: 10.1016/j.chom.2012.07.004.
- Bokshan SL, Doyle M, Becker N, Nalbantoglu I, Chapman WC. Hepatic Hemangiopericytoma/Solitary Fibrous Tumor: A Review of Our Current Understanding and Case Study. Journal Of Gastrointestinal Surgery 2012, 16: 2170-2176. PMID: 22854953, DOI: 10.1007/s11605-012-1947-x.
- Dehdashti F, Grigsby PW, Myerson RJ, Nalbantoglu I, Ma C, Siegel BA. Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study. Molecular Imaging And Biology 2012, 15: 106-113. PMID: 22684813, PMCID: PMC3659775, DOI: 10.1007/s11307-012-0566-y.
- Carvalho F, Nalbantoglu I, Aitken J, Uchiyama R, Su Y, Doho G, Vijay-Kumar M, Gewirtz A. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunology 2012, 5: 288-298. PMID: 22318495, PMCID: PMC3328601, DOI: 10.1038/mi.2012.8.
- Carvalho FA, Nalbantoglu I, Ortega-Fernandez S, Aitken JD, Su Y, Koren O, Walters WA, Knight R, Ley RE, Vijay-Kumar M, Gewirtz AT. Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 2011, 61: 373. PMID: 21646247, DOI: 10.1136/gut.2011.240556.
- Saidi R, Ahad A, Talik J, Nalbantoglu I, Jacobs M. The Expression Of Interferon Receptor Alpha/Beta In Human Pancreatic Cancer In Nude Mice Is Essential For Tumor Response To Interferon Alpha Treatment. Journal Of Surgical Research 2011, 165: 335. DOI: 10.1016/j.jss.2010.11.195.
- Saidi RF, Ahad A, Tilak J, Nalbantoglu I, Jacobs MJ. The Expression of Interferon Receptor α/β in Human Pancreatic Cancer in Nude Mice is Essential for Tumor Response to Interferon α Treatment. Journal Of Surgical Research 2010, 173: 309-313. PMID: 21067774, DOI: 10.1016/j.jss.2010.09.044.
- Jacob JB, Kong YC, Nalbantoglu I, Snower DP, Wei WZ. Tumor Regression following DNA Vaccination and Regulatory T Cell Depletion in neu Transgenic Mice Leads to an Increased Risk for Autoimmunity. The Journal Of Immunology 2009, 182: 5873-5881. PMID: 19380836, PMCID: PMC3833444, DOI: 10.4049/jimmunol.0804074.
- Saidi R, Chang J, Brooks S, Nalbantoglu I, Adsay V, Jacobs M. Ischemic Preconditioning and Intermittent Clamping Increase the Tolerance of Fatty Liver to Hepatic Ischemia-Reperfusion Injury in the Rat. Transplantation Proceedings 2007, 39: 3010-3014. PMID: 18089311, DOI: 10.1016/j.transproceed.2007.09.044.
- Saidi RF, Ahad A, Escobar R, Nalbantoglu I, Adsay V, Jacobs MJ. Comparison between staple and vessel sealing device for parynchemal transection in laparoscopic liver surgery in a swine model. Hepato Pancreato Biliary 2007, 9: 440-443. PMID: 18345291, PMCID: PMC2215357, DOI: 10.1080/13651820701658219.
- Jacob J, Kong Y, Nalbantoglu I, Snower D, Wei W. Th1 and Th17 in tumor Immunity versus autoimmunity (128.15). The Journal Of Immunology 2007, 178: s213-s213. DOI: 10.4049/jimmunol.178.supp.128.15.
- Saidi RF, Chang J, Verb S, Brooks S, Nalbantoglu I, Adsay V, Jacobs MJ. The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver. The American Journal Of Surgery 2007, 193: 345-348. PMID: 17320532, DOI: 10.1016/j.amjsurg.2006.09.017.
- Saidi R, Chang J, Brooks S, Verb S, Nalbantoglu I, Adsay V, Jacobs M. EFFECT OF METHYLPREDNISOLONE ON LIVER ISCHEMIAREPERFUSION INJURY. Transplantation 2006, 82: 203. DOI: 10.1097/00007890-200607152-00420.
Departments and Programs
Titles
- Associate Professor of Pathology
Education & Training
- MDEge University School of Medicine, M.D.
Additional Information
Publications
- Castrodad-Rodríguez C, Cheng J, Westerhoff M, Liang G, Lin J, Nalbantoglu I, Hu S, Sekhri R, Panarelli N. Clinical and Pathological Correlation in Concomitant Celiac Disease and Eosinophilic Esophagitis Suggests Separate Etiologies. International Journal Of Surgical Pathology 2023, 32: 27-34. PMID: 37050846, DOI: 10.1177/10668969231167526.
- Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development.Tan W, Tian M, Ruzgar N, Hengartner A, Sailo B, Ang-Olson O, Ubas A, John N, Yaghoobi V, Tang H, Sharma A, Nalbantoglu I, Ahuja N. Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development. Journal Of Clinical Oncology 2023, 41: 189-189. DOI: 10.1200/jco.2023.41.4_suppl.189.
- Nalbantoglu I, Misdraji J. Approach to the liver biopsy diagnosis of adult cholangiopathies. Diagnostic Histopathology 2023, 29: 23-35. DOI: 10.1016/j.mpdhp.2022.10.004.
- Byrnes K, Vachharajani N, Doyle MM, Nalbantoglu I. Liver allograft findings of donation after cardiac death versus brain death in recipients with hepatitis C related cirrhosis: a matched histologic comparison. Human Pathology 2022, 122: 25-31. PMID: 35085598, DOI: 10.1016/j.humpath.2022.01.005.
- Verma A, Nalbantoglu I, Barbieri A. Metastatic Neoplasms of the Large Bile Ducts- A Clinicopathological Study. American Journal Of Clinical Pathology 2021, 156: s58-s58. DOI: 10.1093/ajcp/aqab191.119.
- Hu X, Lucas E, Hammer S, Gopal P, Bhalla A, Panarelli N, Westerhoff M, Cheng J, Nalbantoglu I. H. pylori Pattern Gastritis with Negative Helicobacter Immunohistochemical Stain: Does A Specific Comment in Pathology Report Impact Clinical Management? American Journal Of Clinical Pathology 2021, 156: s67-s68. DOI: 10.1093/ajcp/aqab191.140.
- Gibson JA, Finberg KE, Nalbantoglu I, Cecchini M, Ganzak A, Walther Z, Sklar JL, Eder JP, Goldberg SB. Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan. The Lancet Oncology 2021, 22: 306-307. PMID: 33662283, DOI: 10.1016/s1470-2045(20)30683-5.
- Abu‐Alreesh S, Rosen D, Nalbantoglu I, Arbizu RA. Gastric Xanthoma. Journal Of Pediatric Gastroenterology And Nutrition 2021, 73: e26-e26. PMID: 33605661, DOI: 10.1097/mpg.0000000000003085.
- Blanc V, Riordan JD, Soleymanjahi S, Nadeau J, Nalbantoglu I, Xie Y, Molitor EA, Madison BB, Brunt EM, Mills JC, Rubin DC, Ng I, Ha Y, Roberts LR, Davidson NO. Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis and hepatocellular cancer. Journal Of Clinical Investigation 2021, 131 PMID: 33445170, PMCID: PMC7773377, DOI: 10.1172/jci138699.
- González IA, Hartley CP, Nalbantoglu I. Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft. American Journal Of Clinical Pathology 2020, 155: 435-445. PMID: 33252121, DOI: 10.1093/ajcp/aqaa147.
- Aranake-Chrisinger J, Dassopoulos T, Yan Y, Nalbantoglu I. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation. World Journal Of Gastroenterology 2020, 26: 4126-4139. PMID: 32821074, PMCID: PMC7403798, DOI: 10.3748/wjg.v26.i28.4126.
- Blanc V, Xie Y, Riordan J, Nadeau J, Nalbantoglu I, Soleymanjahi S, Madison B, Brunt E, Molitor E, Mills J, Ng I, Ha Y, Roberts L, Davidson N. 691 RNA BINDING PROTEIN APOBEC1 COMPLEMENTATION FACTOR (A1CF) ALTERS HEPATIC LIPOGENIC AND PROLIFERATIVE PATHWAYS PROMOTING SPONTANEOUS TUMORIGENESIS. Gastroenterology 2020, 158: s-1286. DOI: 10.1016/s0016-5085(20)33879-8.
- Tang H, Sharma A, Nalbantoglu I, Hasan N, Levchenko A, Ahuja N. Abstract C54: GATA6 level is a prognostic biomarker for pancreatic cancer in African American patients. Cancer Research 2019, 79: c54-c54. DOI: 10.1158/1538-7445.panca19-c54.
- Nalbantoglu I, Jain D. Cryptogenic cirrhosis: Old and new perspectives in the era of molecular and genomic medicine. Seminars In Diagnostic Pathology 2019, 36: 389-394. PMID: 31395291, DOI: 10.1053/j.semdp.2019.07.003.
- Yang C, Tarabishy Y, Dassopoulos T, Nalbantoglu I. Clinical, Histologic, and Immunophenotypic Features of Serrated Polyps in Patients With Inflammatory Bowel Disease. Gastroenterology Research 2018, 11: 355-360. PMID: 30344807, PMCID: PMC6188039, DOI: 10.14740/gr1064w.
- Joseph NM, Brunt EM, Marginean C, Nalbantoglu I, Snover DC, Thung SN, Yeh MM, Umetsu SE, Ferrell LD, Gill RM. Frequent GNAQ and GNA14 Mutations in Hepatic Small Vessel Neoplasm. The American Journal Of Surgical Pathology 2018, 42: 1201-1207. PMID: 29975248, DOI: 10.1097/pas.0000000000001110.
- Liss KHH, McCommis KS, Chambers KT, Pietka TA, Schweitzer GG, Park SL, Nalbantoglu I, Weinheimer CJ, Hall AM, Finck BN. The impact of diet‐induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury. Liver Transplantation 2018, 24: 908-921. PMID: 29729104, PMCID: PMC6097916, DOI: 10.1002/lt.25189.
- Gopal P, Gibson JA, Lisovsky M, Nalbantoglu I. Unique causes of esophageal inflammation: a histopathologic perspective. Annals Of The New York Academy Of Sciences 2018, 1434: 219-226. PMID: 29766506, DOI: 10.1111/nyas.13732.
- Zhang X, Patil D, Odze RD, Zhao L, Lisovsky M, Guindi M, Riddell R, Bellizzi A, Yantiss RK, Nalbantoglu I, Appelman HD. The microscopic anatomy of the esophagus including the individual layers, specialized tissues, and unique components and their responses to injury. Annals Of The New York Academy Of Sciences 2018, 1434: 304-318. PMID: 29761508, DOI: 10.1111/nyas.13705.
- Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A. Genomic regions associated with susceptibility to Barrett’s esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study. PLOS ONE 2017, 12: e0184962. PMID: 29073141, PMCID: PMC5657624, DOI: 10.1371/journal.pone.0184962.
- Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, Heiken JP, Fowler KJ. Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014. Radiology 2017, 286: 158-172. PMID: 28853673, DOI: 10.1148/radiol.2017170114.
- Pehlivanoglu B, Hassoy H, Calle C, Dendooven A, Nalbantoglu I, Reshchikova L, Gul G, Doganavsargil B. How does it feel to be a pathology resident? Results of a survey on experiences and job satisfaction during pathology residency. Virchows Archiv 2017, 471: 413-422. PMID: 28624995, DOI: 10.1007/s00428-017-2167-2.
- McCommis KS, Hodges WT, Brunt EM, Nalbantoglu I, McDonald WG, Holley C, Fujiwara H, Schaffer JE, Colca JR, Finck BN. Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis. Hepatology 2017, 65: 1543-1556. PMID: 28027586, PMCID: PMC5397348, DOI: 10.1002/hep.29025.
- Olsen S, Jin L, Fields RC, Yan Y, Nalbantoglu I. Tumor budding in intestinal-type gastric adenocarcinoma is associated with nodal metastasis and recurrence. Human Pathology 2017, 68: 26-33. PMID: 28428104, DOI: 10.1016/j.humpath.2017.03.021.
- Sun X, Chandar A, Canto M, Thota P, Brock M, Shaheen N, Beer D, Wang J, Falk G, Iyer P, Abrams J, Venkat-Ramani M, Veigl M, miron A, Willis J, Patil D, Nalbantoglu I, Guda K, Markowitz S, zhu X, Elston R, Chak A. Sa1139 Identification of Genomic Regions Associated with Susceptibility to Barrett’s Esophagus and Esophageal Adenocarcinoma in African Americans: The Cross Betrnet Admixture Study. Gastroenterology 2017, 152: s233. DOI: 10.1016/s0016-5085(17)31069-7.
- Randolph GJ, Bala S, Rahier JF, Johnson MW, Wang PL, Nalbantoglu I, Dubuquoy L, Chau A, Pariente B, Kartheuser A, Zinselmeyer BH, Colombel JF. Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease. American Journal Of Pathology 2016, 186: 3066-3073. PMID: 27746181, PMCID: PMC5225286, DOI: 10.1016/j.ajpath.2016.07.026.
- Lang G, Nalbantoglu I, Early D, Mullady D, Kushnir V. High Recurrence Rate of Large Hyperplastic Polyps After Endoscopic Resection. The American Journal Of Gastroenterology 2016, 111: s499. DOI: 10.14309/00000434-201610001-01148.
- Nalbantoglu I, Blanc V, Davidson NO. Characterization of Colorectal Cancer Development in Apcmin/+ Mice. 2016, 1422: 309-327. PMID: 27246043, PMCID: PMC5061497, DOI: 10.1007/978-1-4939-3603-8_27.
- Pehlivanoğlu B, Doğanavşargil B, Sezak M, Nalbantoğlu İ, Korkmaz M. Gastrointestinal Parasitosis: Histopathological Insights to Rare But Intriguing Lesions of the Gastrointestinal Tract. Turkish Journal Of Pathology 2016, 32: 82-90. PMID: 27136106, DOI: 10.5146/tjpath.2015.01350.
- Gill RM, Buelow B, Mather C, Joseph NM, Alves V, Brunt EM, Liu TC, Makhlouf H, Marginean C, Nalbantoglu I, Sempoux C, Snover DC, Thung SN, Yeh MM, Ferrell LD. Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential. Human Pathology 2016, 54: 143-151. PMID: 27090685, PMCID: PMC5242228, DOI: 10.1016/j.humpath.2016.03.018.
- Randolph G, Bala S, Rahier J, Wang P, Zinselmeyer B, Nalbantoglu I, Cella M, Colonna M, Newberry R, Dubuquoy L, Chau A, Pariente B, Kartheuser A, Colombel J. Sa1866 Mesenteric Lymphatic and Venous Vasculopathy in Crohn's Disease. Gastroenterology 2016, 150: s385. DOI: 10.1016/s0016-5085(16)31355-5.
- Sayuk G, Nalbantoglu I, Hasak S, Rubin D, Nix B, Gyawali C, Patel A. Mo1649 High Colonic Mast Cell Counts May Be Associated with Lower Extra-intestinal Comorbidity in Irritable Bowel Syndrome (IBS). Gastroenterology 2016, 150: s742. DOI: 10.1016/s0016-5085(16)32520-3.
- Doyle MB, Collins K, Vachharajani N, Lowell JA, Shenoy S, Nalbantoglu I, Byrnes K, Garonzik-Wang J, Wellen J, Lin Y, Chapman WC. Outcomes Using Grafts from Donors after Cardiac Death. Journal Of The American College Of Surgeons 2015, 221: 142-152. PMID: 26095563, DOI: 10.1016/j.jamcollsurg.2015.03.053.
- Lin J, Cummings OW, Greenson JK, House MG, Liu X, Nalbantoglu I, Pai R, Davidson DD, Reuss SA. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma. Scandinavian Journal Of Gastroenterology 2015, 50: 447-453. PMID: 25635498, DOI: 10.3109/00365521.2014.962603.
- Kushnir VM, Nalbantoglu I, Watson R, Goodwin J, Safar E, Chokshi RV, Azar RR, Davidson NO. Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Digestive Diseases And Sciences 2014, 59: 2757-64. PMID: 24925148, PMCID: PMC4213267, DOI: 10.1007/s10620-014-3245-9.
- Nalbantoglu I, Tan B, Linehan D, Gao F, Brunt E. Oxaliplatin‐induced liver injury. Journal Of Digestive Diseases 2014, 15: 553-560. PMID: 25060628, DOI: 10.1111/1751-2980.12177.
- Giammanco A, Blanc V, Montenegro G, Klos C, Xie Y, Kennedy S, Luo J, Chang SH, Hla T, Nalbantoglu I, Dharmarajan S, Davidson NO. Intestinal Epithelial HuR Modulates Distinct Pathways of Proliferation and Apoptosis and Attenuates Small Intestinal and Colonic Tumor Development. Cancer Research 2014, 74: 5322-5335. PMID: 25085247, PMCID: PMC4167566, DOI: 10.1158/0008-5472.can-14-0726.
- Nalbantoglu I, Brunt E. Role of liver biopsy in nonalcoholic fatty liver disease. World Journal Of Gastroenterology 2014, 20: 9026-37. PMID: 25083076, PMCID: PMC4112884, DOI: 10.3748/wjg.v20.i27.9026.
- Blanc V, Klos C, Giammanco A, Montenegro G, Xie Y, Kennedy S, Luo J, Chang S, Nalbantoglu I, Hla T, Dharmarajan S, Davidson N. 294 Conditional Intestine-Specific HuR Deletion (HuR-IKO) Modulates Distinct Wnt-Dependent and Independent Pathways of Proliferation and Apoptosis With No Effect on Ileal ASBT Expression or Bile Acid Metabolism. Gastroenterology 2014, 146: s-70. DOI: 10.1016/s0016-5085(14)60253-5.
- Tarabishy Y, Nalbantoglu I. Su1305 Clinical, Endoscopic, and Histologic Features With Utilization of Ki67 Staining in Serrated Polyps in Patients With Inflammatory Bowel Disease. Gastroenterology 2014, 146: s-431-s-432. DOI: 10.1016/s0016-5085(14)61551-1.
- Kushnir V, Nalbantoglu I, Watson R, Chokshi R, Safar E, Goodwin J, Azar R, Davidson N. 674 Advanced Colorectal Adenomas in Patients Under 45 Years of Age Are Mostly Sporadic. Gastroenterology 2014, 146: s-119. DOI: 10.1016/s0016-5085(14)60428-5.
- Zhang C, Zhao Z, Osman H, Watson R, Nalbantoglu I, Lin J. Differential expression of miR-31 between inflammatory bowel disease and microscopic colitis. MicroRNA 2014, 3: 155-9. PMID: 25665881, DOI: 10.2174/2211536604666150209115444.
- Asombang A, Safar B, Wang J, Nalbantoglu I. Is a Rectal Mass and Lymphadenopathy Always Rectal Cancer? The American Journal Of Gastroenterology 2013, 108: s360. DOI: 10.14309/00000434-201310001-01228.
- Dharmarajan S, Newberry EP, Montenegro G, Nalbantoglu I, Davis VR, Clanahan MJ, Blanc V, Xie Y, Luo J, Fleshman JW, Kennedy S, Davidson NO. Liver Fatty Acid-Binding Protein (L-Fabp) Modifies Intestinal Fatty Acid Composition and Adenoma Formation in ApcMin/+ Mice. Cancer Prevention Research 2013, 6: 1026-1037. PMID: 23921281, PMCID: PMC3791217, DOI: 10.1158/1940-6207.capr-13-0120.
- Xie Y, Matsumoto H, Nalbantoglu I, Kerr TA, Luo J, Rubin DC, Kennedy S, Davidson NO. Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer. PLOS ONE 2013, 8: e67819. PMID: 23805328, PMCID: PMC3689718, DOI: 10.1371/journal.pone.0067819.
- Montenegro G, Giammanco A, Blanc V, Kennedy S, Luo J, Chang S, Nalbantoglu I, Hla T, Davidson N. Tu1732 Conditional Intestinal-Epithelial Specific HuR Deletion Modifies Murine Intestinal Tumorigenesis. Gastroenterology 2013, 144: s-833. DOI: 10.1016/s0016-5085(13)63096-6.
- Giammanco A, Blanc V, Montenegro G, Kennedy S, Luo J, Chang S, Nalbantoglu I, Hla T, Davidson N. 230 Conditional Intestine-Specific HuR Deletion (HuR-Iko) Modifies Epithelial Growth, Response to Injury and Tumorigenesis. Gastroenterology 2013, 144: s-50. DOI: 10.1016/s0016-5085(13)60176-6.
- Dharmarajan S, Newberry E, Nalbantoglu I, Davis V, Montenegro G, Blanc V, Xie Y, Luo J, Kennedy S, Davidson N. 82 Modulating Intestinal Fatty Acid Flux Attenuates Intestinal Tumorigenesis in APC MIN/+ Mice. Gastroenterology 2013, 144: s-18. DOI: 10.1016/s0016-5085(13)60062-1.
- Carvalho FA, Koren O, Goodrich JK, Johansson ME, Nalbantoglu I, Aitken JD, Su Y, Chassaing B, Walters WA, González A, Clemente JC, Cullender TC, Barnich N, Darfeuille-Michaud A, Vijay-Kumar M, Knight R, Ley RE, Gewirtz AT. Transient Inability to Manage Proteobacteria Promotes Chronic Gut Inflammation in TLR5-Deficient Mice. Cell Host & Microbe 2012, 12: 139-152. PMID: 22863420, PMCID: PMC4310462, DOI: 10.1016/j.chom.2012.07.004.
- Bokshan SL, Doyle M, Becker N, Nalbantoglu I, Chapman WC. Hepatic Hemangiopericytoma/Solitary Fibrous Tumor: A Review of Our Current Understanding and Case Study. Journal Of Gastrointestinal Surgery 2012, 16: 2170-2176. PMID: 22854953, DOI: 10.1007/s11605-012-1947-x.
- Dehdashti F, Grigsby PW, Myerson RJ, Nalbantoglu I, Ma C, Siegel BA. Positron Emission Tomography with [18F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study. Molecular Imaging And Biology 2012, 15: 106-113. PMID: 22684813, PMCID: PMC3659775, DOI: 10.1007/s11307-012-0566-y.
- Carvalho F, Nalbantoglu I, Aitken J, Uchiyama R, Su Y, Doho G, Vijay-Kumar M, Gewirtz A. Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunology 2012, 5: 288-298. PMID: 22318495, PMCID: PMC3328601, DOI: 10.1038/mi.2012.8.
- Carvalho FA, Nalbantoglu I, Ortega-Fernandez S, Aitken JD, Su Y, Koren O, Walters WA, Knight R, Ley RE, Vijay-Kumar M, Gewirtz AT. Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 2011, 61: 373. PMID: 21646247, DOI: 10.1136/gut.2011.240556.
- Saidi R, Ahad A, Talik J, Nalbantoglu I, Jacobs M. The Expression Of Interferon Receptor Alpha/Beta In Human Pancreatic Cancer In Nude Mice Is Essential For Tumor Response To Interferon Alpha Treatment. Journal Of Surgical Research 2011, 165: 335. DOI: 10.1016/j.jss.2010.11.195.
- Saidi RF, Ahad A, Tilak J, Nalbantoglu I, Jacobs MJ. The Expression of Interferon Receptor α/β in Human Pancreatic Cancer in Nude Mice is Essential for Tumor Response to Interferon α Treatment. Journal Of Surgical Research 2010, 173: 309-313. PMID: 21067774, DOI: 10.1016/j.jss.2010.09.044.
- Jacob JB, Kong YC, Nalbantoglu I, Snower DP, Wei WZ. Tumor Regression following DNA Vaccination and Regulatory T Cell Depletion in neu Transgenic Mice Leads to an Increased Risk for Autoimmunity. The Journal Of Immunology 2009, 182: 5873-5881. PMID: 19380836, PMCID: PMC3833444, DOI: 10.4049/jimmunol.0804074.
- Saidi R, Chang J, Brooks S, Nalbantoglu I, Adsay V, Jacobs M. Ischemic Preconditioning and Intermittent Clamping Increase the Tolerance of Fatty Liver to Hepatic Ischemia-Reperfusion Injury in the Rat. Transplantation Proceedings 2007, 39: 3010-3014. PMID: 18089311, DOI: 10.1016/j.transproceed.2007.09.044.
- Saidi RF, Ahad A, Escobar R, Nalbantoglu I, Adsay V, Jacobs MJ. Comparison between staple and vessel sealing device for parynchemal transection in laparoscopic liver surgery in a swine model. Hepato Pancreato Biliary 2007, 9: 440-443. PMID: 18345291, PMCID: PMC2215357, DOI: 10.1080/13651820701658219.
- Jacob J, Kong Y, Nalbantoglu I, Snower D, Wei W. Th1 and Th17 in tumor Immunity versus autoimmunity (128.15). The Journal Of Immunology 2007, 178: s213-s213. DOI: 10.4049/jimmunol.178.supp.128.15.
- Saidi RF, Chang J, Verb S, Brooks S, Nalbantoglu I, Adsay V, Jacobs MJ. The effect of methylprednisolone on warm ischemia-reperfusion injury in the liver. The American Journal Of Surgery 2007, 193: 345-348. PMID: 17320532, DOI: 10.1016/j.amjsurg.2006.09.017.
- Saidi R, Chang J, Brooks S, Verb S, Nalbantoglu I, Adsay V, Jacobs M. EFFECT OF METHYLPREDNISOLONE ON LIVER ISCHEMIAREPERFUSION INJURY. Transplantation 2006, 82: 203. DOI: 10.1097/00007890-200607152-00420.
Departments and Programs